AUD 0.43
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 91.65 Million AUD | 9.61% |
2023 | 83.61 Million AUD | 15.2% |
2022 | 72.58 Million AUD | 15.75% |
2021 | 62.7 Million AUD | 9.44% |
2020 | 57.29 Million AUD | -2.71% |
2019 | 58.89 Million AUD | 12.4% |
2018 | 52.39 Million AUD | 6.22% |
2017 | 49.32 Million AUD | 11.89% |
2016 | 44.08 Million AUD | 28.01% |
2015 | 34.43 Million AUD | 13.75% |
2014 | 30.27 Million AUD | 63.74% |
2013 | 18.48 Million AUD | 20.62% |
2012 | 15.32 Million AUD | 22.5% |
2011 | 12.51 Million AUD | 13.84% |
2010 | 10.99 Million AUD | 37.48% |
2009 | 7.99 Million AUD | 118.56% |
2008 | 3.65 Million AUD | 60.91% |
2007 | 2.27 Million AUD | 27.3% |
2006 | 1.78 Million AUD | 373.56% |
2005 | 377.12 Thousand AUD | 1239.83% |
2004 | 28.14 Thousand AUD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 FY | 91.65 Million AUD | 9.61% |
2024 Q4 | 46.53 Million AUD | 0.0% |
2024 Q2 | 45.11 Million AUD | 0.0% |
2023 Q4 | 43.65 Million AUD | 0.0% |
2023 Q2 | 39.96 Million AUD | 0.0% |
2023 FY | 83.61 Million AUD | 15.2% |
2022 Q2 | 33.93 Million AUD | 0.0% |
2022 Q4 | 38.64 Million AUD | 0.0% |
2022 FY | 72.58 Million AUD | 15.75% |
2021 FY | 62.7 Million AUD | 9.44% |
2021 Q2 | 30.82 Million AUD | 0.0% |
2021 Q4 | 31.88 Million AUD | 0.0% |
2020 Q2 | 33.25 Million AUD | 0.0% |
2020 Q4 | 24.03 Million AUD | 0.0% |
2020 FY | 57.29 Million AUD | -2.71% |
2019 Q4 | 30.07 Million AUD | 0.0% |
2019 FY | 58.89 Million AUD | 12.4% |
2019 Q2 | 28.81 Million AUD | 0.0% |
2018 FY | 52.39 Million AUD | 6.22% |
2018 Q2 | 24.95 Million AUD | 0.0% |
2018 Q4 | 27.43 Million AUD | 0.0% |
2017 Q2 | 23.78 Million AUD | 0.0% |
2017 FY | 49.32 Million AUD | 11.89% |
2017 Q4 | 25.54 Million AUD | 0.0% |
2016 Q2 | 21.33 Million AUD | 0.0% |
2016 Q4 | 22.75 Million AUD | 0.0% |
2016 FY | 44.08 Million AUD | 28.01% |
2015 FY | 34.43 Million AUD | 13.75% |
2015 Q4 | 17.63 Million AUD | 0.0% |
2015 Q2 | 16.8 Million AUD | 0.0% |
2014 FY | 30.27 Million AUD | 63.74% |
2014 Q4 | 17.72 Million AUD | 0.0% |
2014 Q2 | 12.55 Million AUD | 0.0% |
2013 Q2 | 9.02 Million AUD | 0.0% |
2013 FY | 18.48 Million AUD | 20.62% |
2013 Q4 | 9.46 Million AUD | 0.0% |
2012 Q4 | 3.83 Million AUD | 0.0% |
2012 Q1 | 3.12 Million AUD | 0.0% |
2012 Q3 | 3.83 Million AUD | 0.0% |
2012 FY | 15.32 Million AUD | 22.5% |
2012 Q2 | 3.83 Million AUD | 22.5% |
2011 FY | 12.51 Million AUD | 13.84% |
2011 Q1 | 2.72 Million AUD | 0.0% |
2011 Q2 | 3.12 Million AUD | 14.77% |
2011 Q3 | 3.12 Million AUD | 0.0% |
2011 Q4 | 3.12 Million AUD | 0.0% |
2010 Q4 | 2.72 Million AUD | 0.0% |
2010 Q1 | 1.99 Million AUD | 0.0% |
2010 Q2 | 2.72 Million AUD | 36.36% |
2010 Q3 | 2.72 Million AUD | 0.0% |
2010 FY | 10.99 Million AUD | 37.48% |
2009 Q1 | 914.54 Thousand AUD | 0.0% |
2009 Q3 | 1.99 Million AUD | 0.0% |
2009 Q4 | 1.99 Million AUD | 0.0% |
2009 FY | 7.99 Million AUD | 118.56% |
2009 Q2 | 1.99 Million AUD | 118.56% |
2008 Q4 | 914.54 Thousand AUD | 0.0% |
2008 Q3 | 914.54 Thousand AUD | 0.0% |
2008 Q2 | 914.54 Thousand AUD | 60.91% |
2008 Q1 | 568.36 Thousand AUD | 0.0% |
2008 FY | 3.65 Million AUD | 60.91% |
2007 Q1 | 446.48 Thousand AUD | 0.0% |
2007 FY | 2.27 Million AUD | 27.3% |
2007 Q3 | 568.36 Thousand AUD | 0.0% |
2007 Q4 | 568.36 Thousand AUD | 0.0% |
2007 Q2 | 568.36 Thousand AUD | 27.3% |
2006 Q3 | 446.48 Thousand AUD | 0.0% |
2006 Q2 | 446.48 Thousand AUD | 373.57% |
2006 Q4 | 446.48 Thousand AUD | 0.0% |
2006 FY | 1.78 Million AUD | 373.56% |
2006 Q1 | 94.28 Thousand AUD | 0.0% |
2005 Q4 | 94.28 Thousand AUD | 0.0% |
2005 FY | 377.12 Thousand AUD | 1239.83% |
2005 Q3 | 94.28 Thousand AUD | 0.0% |
2005 Q1 | 7036.75 AUD | 0.0% |
2005 Q2 | 94.28 Thousand AUD | 1239.82% |
2004 Q2 | 7036.75 AUD | 0.0% |
2004 Q4 | 7036.75 AUD | 0.0% |
2004 FY | 28.14 Thousand AUD | 0.0% |
2004 Q3 | 7036.75 AUD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
4DMedical Limited | 3.75 Million AUD | -2341.258% |
Adherium Limited | 840.98 Thousand AUD | -10798.101% |
Aroa Biosurgery Limited | 63.35 Million AUD | -44.657% |
Atomo Diagnostics Limited | 4.08 Million AUD | -2142.757% |
Anteris Technologies Ltd | 4.11 Million AUD | -2129.367% |
Control Bionics Limited | 5.12 Million AUD | -1687.652% |
CardieX Limited | 10.9 Million AUD | -740.401% |
Compumedics Limited | 49.71 Million AUD | -84.338% |
Cochlear Limited | 2.25 Billion AUD | 95.941% |
CleanSpace Holdings Limited | 15.72 Million AUD | -482.959% |
Cyclopharm Limited | 27.13 Million AUD | -237.703% |
EMVision Medical Devices Ltd | 11.21 Million AUD | -716.912% |
Nova Eye Medical Limited | 23.32 Million AUD | -292.931% |
HeraMED Limited | 402.89 Thousand AUD | -22648.015% |
Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -14788.862% |
ImpediMed Limited | 10.31 Million AUD | -788.178% |
InhaleRx Limited | 1.2 Million AUD | -7511.924% |
LBT Innovations Limited | 1.25 Million AUD | -7197.06% |
Micro-X Limited | 15.22 Million AUD | -502.096% |
Neurotech International Limited | 1963.00 AUD | -4668828.63% |
OncoSil Medical Limited | 1.56 Million AUD | -5754.865% |
PolyNovo Limited | 103.19 Million AUD | 11.184% |
Respiri Limited | 456.91 Thousand AUD | -19958.713% |
Universal Biosensors, Inc. | 6.63 Million AUD | -1281.778% |
Uscom Limited | 3.72 Million AUD | -2359.213% |
Visioneering Technologies, Inc. | 8.67 Million AUD | -957.106% |